Once‐weekly prophylactic treatment vs. on‐demand treatment with nonacog alfa in patients with moderately severe to severe haemophilia B-Reference-Cited by-同舟云学术

Once‐weekly prophylactic treatment vs. on‐demand treatment with nonacog alfa in patients with moderately severe to severe haemophilia B

Author:

Kavakli K.¹,Smith L.²,Kuliczkowski K.³,Korth‐Bradley J.²,You C. W.⁴,Fuiman J.²,Zupančić‐Šalek S.⁵,Abdul Karim F.⁶,Rendo P.²

Affiliation:

1. Department of Pediatric Hematology Ege University Children's Hospital Izmir Turkey

2. Pfizer Inc Collegeville PA USA

3. University of Wroclaw Wroclaw Poland

4. Eulji University Daejeon Korea

5. University Hospital Centre Rebro Zagreb Croatia

6. National Blood Centre in Kuala Lumpur Kuala Lumpur Malaysia

Funder

Pfizer

Publisher

Wiley

Subject

Genetics (clinical),Hematology,General Medicine

Link

Reference29 articles.

2. Replacement therapy with recombinant factor IX. A multicentre evaluation of current dosing practices in Italy;Rocca A;Blood Transfus,2011

Cited by 47 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献